Analyst Activity – Instinet Initiates Coverage On Solid Biosciences (NASDAQ:SLDB) With a Buy

Analyst Ratings For Solid Biosciences (NASDAQ:SLDB)

Story continues below

Today, Instinet initiated coverage on Solid Biosciences (NASDAQ:SLDB) with a Buy with a price target of $52.00.

Some recent analyst ratings include

  • 2/20/2018-Instinet initiated coverage with a Buy rating.
  • 2/20/2018-Leerink Swann initiated coverage with a Outperform rating.
  • 2/20/2018-JPMorgan Chase & Co. initiated coverage with a Neutral rating.
  • 2/20/2018-Goldman Sachs Group initiated coverage with a Neutral rating.

    Recent Trading Activity for Solid Biosciences (NASDAQ:SLDB)
    Shares of Solid Biosciences closed the previous trading session at 24.58 down -0.35 1.40% with 23.010000228881836 shares trading hands.

    An ad to help with our costs